Lam Research Corporation

LRCX Technology · Semiconductor Equipment & Materials
Delayed 15 min
Last close
$410.91
Jun 29, 2026
52-week range
$90.94 — $414.98
-1% from high
Market cap
513.9B
Diluted basis
Dividend yield
27.0%
P/E
77.4
Trailing
Filing.fyi verdict · Jun 29, 2026

Fairly valued.

Fairly Valued (Neutral) — Filing.fyi's reading derived from the latest 10-K and forensic scores.

Neutral
RED DEEP / 100
Composite Health
AI synthesis · grounded in this ticker's SEC filings · drag to highlight, releases the composer

What the filing actually says.

AI · wry-editorial preset

Lam Research Corporation’s 2026 Q3 10-Q presents a company with notable top-line growth. Revenue, the total sales generated from operations, increased to $5,841,488 thousand for the three months ended March 29, 2026, from $4,720,175 thousand in the prior year period. This represents a substantial increase, mirrored in the nine-month figures, where revenue reached $16,510,452 thousand compared to $13,264,198 thousand previously. The accompanying MD&A describes Lam Research as a global supplier of innovative wafer fabrication equipment and services to the semiconductor industry, noting core competencies in areas like nanoscale manufacturing enablement and advanced systems engineering. Gross margin, the revenue remaining after deducting cost of goods sold, also saw a proportional increase, reaching $2,910,527 thousand for the quarter.

The forensic accounting metrics for this filing are not available, which limits a quantitative assessment of potential financial irregularities or distress. Beneish’s M-Score (Beneish, 1999) — an eight-ratio earnings-manipulation detector — is not provided. Similarly, Altman’s Z″ (Altman, 1968) — a bankruptcy-distress index — is absent, preventing an evaluation of the company’s solvency risk. Piotroski’s F-Score (Piotroski, 2000), a nine-point fundamental strength scan, is also unavailable, precluding an assessment of operational and financial health. Lastly, the Fog Index (Gunning, 1952) — a readability score where 12 equals newspaper and 18+ indicates obfuscation — is not calculated for this document.

The MD&A’s executive summary provides a foundational understanding of the company’s operations, emphasizing its role in helping customers build smaller and better performing devices for various electronic products, including mobile phones. This section also directs readers to the Condensed Consolidated Financial Statements within the 10-Q and the financial statements in the annual report on Form 10-K for the year ended June 29, 2025. This cross-reference is standard practice, but it underscores the importance of reviewing the full suite of disclosures for a comprehensive financial picture, particularly given the detailed nature of semiconductor manufacturing and its associated capital expenditures. The risk factors section, Item 1A, is presented as a table of contents in the provided excerpt, rather than specific enumerated risks.

This reading, constrained by the provided excerpts and the absence of forensic scores, offers a limited view of Lam Research Corporation’s financial health. While the reported revenue and gross margin figures suggest a period of growth, the lack of Beneish, Altman, Piotroski, and Fog scores means deeper insights into earnings quality, bankruptcy risk, fundamental strength, or disclosure clarity cannot be derived from this specific data set. A complete understanding would require access to the full financial statements, notes, and a comprehensive risk factors discussion. Therefore, this filing primarily serves as an update on top-line performance and a high-level business description, rather than a detailed forensic examination of its financial integrity or operational efficiency.

SEC filings · last 12 months

Filing timeline

View all on EDGAR →
  • Apr 23, 2026
    10-Q
    Quarterly report (2026-03-29)Period: 2026-03-290
    Read →
  • Apr 22, 2026
    8-K
    Material event (2026-04-22)### Item 2.02 and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwi0
    Read →
  • Feb 3, 2026
    8-K
    Material event (2026-01-30)No specific items found in 8-K.0
    Read →
  • Jan 28, 2026
    8-K
    Material event (2026-01-28)### Item 2.02 and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwi0
    Read →
  • Sep 24, 2025
    DEF 14A
    Proxy statement (2025-11-04)0
    Read →
  • Aug 11, 2025
    10-K
    Annual report (2025-06-29)Period: 2025-06-290
    Read →
Member feature · Custom Q&A
Ask anything about LRCX's filings.
Plain-English answer, cited from the company's own 10-K and recent 10-Qs. No buy/sell advice.
Ask a question →
Further reading · curated for this filing

If this case caught your eye

Affiliate links — Filing.fyi earns a commission on Amazon purchases. We pick the books first, attach the link second.

Financial Shenanigans

Howard M. Schilit

Schilit's framework for the seven shenanigan types is the standard reference for the kind of MD&A pattern-matching this site does.

View on Amazon →

The Interpretation of Financial Statements

Benjamin Graham

The original — and still the clearest — explanation of why working-capital trends matter more than headline earnings.

View on Amazon →
Quality of Earnings

Quality of Earnings

Thornton L. O'glove

Out of print, expensive, worth it. The chapter on receivables-vs-revenue divergence applies almost word-for-word to most distressed filings.

View on Amazon →